Cancer Biology and Therapeutics The Cancer Biology and Therapeutics (CBT) Program brings together 37 faculty, representing 12 departments at Dartmouth?s Geisel School of Medicine (Geisel), its Guarini School of Graduate and Advanced Studies, and the Dartmouth-Hitchcock Medical Center (DH), with research interests relevant to three central CBT Program themes: 1) Cancer cell signaling and metabolism, 2) Cell cycle biology and genome stability, and 3) Chromatin biology and oncogenic transcription. The shared goals of the CBT Program are to: i) advance the understanding of the basic mechanisms that underlie cancer initiation, progression, and metastasis to support prevention, diagnosis and treatment of cancer; ii) identify and validate new pathways and molecular targets for effective therapeutic intervention; iii) facilitate bi-directional translation to develop and improve novel therapeutic and diagnostic strategies. Peer-reviewed cancer-related research direct cost support currently totals $7.0M, with NCI funding representing 25% ($1.8M) and total direct costs summing to $7.9M. Twenty (20) CBT Program Members currently have a total of 28 CCSG-defined R01-equivalent awards. Using the same definition of cancer-related direct costs in 2014 (i.e., excluding all indirects as well as training and administrative direct costs), peer-reviewed cancer-related research direct costs ($7.0M) are up 14% compared to the combination of Cancer Mechanisms and Molecular Therapeutics in 2014 ($6.1M). Since 2015, the CBT Program has 446 cancer-related publications, 22% (98) intra-programmatic, 24% (109) inter-programmatic, 52% (232) with investigators from other institutions, and 24% (97) in high impact journals (i.e., impact factor >8). Compared to the combination of Cancer Mechanisms and Molecular Therapeutics in 2014, intra- programmatic publications have increased, to 22% from 15%, along with inter-programmatic (to 24% from 21%) and high impact (to 24% from 22%) in the current reporting period. The CBT Program will continue to pursue the proposed Specific Aims through building and strengthening multidisciplinary collaborations between basic, translational, and clinical researchers, mentorship of junior faculty members to academic independence, and promotion of partnerships of clinicians and laboratory scientists to drive the development of investigator- initiated clinical studies.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA023108-42
Application #
10165519
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2020-12-01
Budget End
2021-11-30
Support Year
42
Fiscal Year
2021
Total Cost
Indirect Cost
Name
Dartmouth College
Department
Type
DUNS #
041027822
City
Hanover
State
NH
Country
United States
Zip Code
03755
Soneji, Samir S; Sung, Hai-Yen; Primack, Brian A et al. (2018) Quantifying population-level health benefits and harms of e-cigarette use in the United States. PLoS One 13:e0193328
Durand, Marie-Anne; Yen, Renata West; O'Malley, A James et al. (2018) What matters most: protocol for a randomized controlled trial of breast cancer surgery encounter decision aids across socioeconomic strata. BMC Public Health 18:241
Courtney, Andrea L; Rapuano, Kristina M; Sargent, James D et al. (2018) Brain Reward Responses Are Behaviorally Relevant: The Authors Respond. J Stud Alcohol Drugs 79:41-42
Tosteson, Anna N A; Yang, Qian; Nelson, Heidi D et al. (2018) Second opinion strategies in breast pathology: a decision analysis addressing over-treatment, under-treatment, and care costs. Breast Cancer Res Treat 167:195-203
Molodtsov, Aleksey; Turk, Mary Jo (2018) Tissue Resident CD8 Memory T Cell Responses in Cancer and Autoimmunity. Front Immunol 9:2810
Elder, David E; Piepkorn, Michael W; Barnhill, Raymond L et al. (2018) Pathologist characteristics associated with accuracy and reproducibility of melanocytic skin lesion interpretation. J Am Acad Dermatol 79:52-59.e5
Rutter, Carolyn M; Kim, Jane J; Meester, Reinier G S et al. (2018) Effect of Time to Diagnostic Testing for Breast, Cervical, and Colorectal Cancer Screening Abnormalities on Screening Efficacy: A Modeling Study. Cancer Epidemiol Biomarkers Prev 27:158-164
Lin, Anping; Yin, Juan; Cheng, Chao et al. (2018) Decreased expression of FOXA2 promotes eutopic endometrial cell proliferation and migration in patients with endometriosis. Reprod Biomed Online 36:181-187
Punshon, Tracy; Jackson, Brian P (2018) Essential micronutrient and toxic trace element concentrations in gluten containing and gluten-free foods. Food Chem 252:258-264
Pernas, Sonia; Martin, Miguel; Kaufman, Peter A et al. (2018) Balixafortide plus eribulin in HER2-negative metastatic breast cancer: a phase 1, single-arm, dose-escalation trial. Lancet Oncol 19:812-824

Showing the most recent 10 out of 1911 publications